Engagement of Veterans With Lung Cancer
Part of paid clinical trials in Palo Alto, California.
- Sponsor
- Palo Alto Veterans Institute for Research
- Study ID
- NCT07219251
- Status
- Recruiting
Conditions
- Lung Adenocarcinoma
- Lung Adenocarcinoma With Bronchiolo-alveolar Feature
- Lung Cancer (NSCLC)
- Lung Cancer, Non-Small Cell
- Lung Cancer, Small Cell
- Lung Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Lay Health Worker (LHW) Planning — BEHAVIORALPatients randomized to the LHW group will receive usual care provided by their oncology (or primary) clinical team along with an initial 30-minute telephone call with the LHW from Palo Alto, followed by weekly 15-minute phone calls (or as needed) for 6months. These calls are designed to assist with healthcare planning, symptom management, and discussions about care preferences and goals.
- Usual Care Group — OTHERParticipants randomized to the usual care group will receive usual care provided by their oncology clinical team. These teams have been trained in symptom assessment, goals-of-care (GoC) discussions, and documentation of such clinical services. As part of usual care, participants may engage in symptom and GoC discussions at any time, initiated by either the patient or the clinician.
Study Details
This research study will help our understanding of whether additional support for Veterans with lung cancer can improve their quality of life.
Key Dates
- Start date
- Feb 27, 2026
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2030
- Completion
- Dec 31, 2032
Study Design
- Enrollment
- 194 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Active Comparator: Usual Care - Arm APatients randomized to this group will receive usual care provided by their oncology(or primary) clinical team.
- Experimental: Intervention Lay Health Worker (LHW) - Arm BParticipants randomized to this arm of the study will receive usual care with supplemental education and support provided by a lay health worker (LHW) to assist with healthcare planning, symptom management, and discussions about care preferences and goals.
Primary Outcome Measure
Health-Related Quality of Life [ Time Frame: At Baseline (time of enrollment), 3, 6, 9, and 12 months post-enrollment ]
Central Contacts
- Manali I Patel, MD MPH MS6504935000
- Madhuri Agrawal, MS650-304-7744
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Veterans Affairs Palo Alto Health Care System (VAPAHCS) | Palo Alto | California | 94304 |
Find similar trials in Palo Alto, CA
By condition
By specialty
Related Studies
- Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During SurgeryPHASE1/PHASE2 · Recruiting · Stanford University · Palo Alto, California
- Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsPHASE1 · Recruiting · Anusha Kalbasi · Duarte, California
- Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung CancerPHASE2 · Recruiting · National Cancer Institute (NCI) · Buena Park, California
- Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung CancerRecruiting · City of Hope Medical Center · Duarte, California